NP / PA
Thomas, Ashley
Thomas, Ashley was paid $421K by Medicaid between Jan 2018 and Nov 2024, across 34 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 62% of everything it billed.
33Billing provider infoTHOMAS, ASHLEY
HOMER, LA 71040
HOMER, LA 71040
33aNPI1497787691assigned 07/07/2006
33bProvider typeFamily Nurse Practitioner
28Total paid$421K
24GClaims23,937
24DCodes billed34
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Louisiana
Rank by total paid#36 of 254
Median peer was paid$4K
This provider vs. median112×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,623 | $63K | |
| 2019 | 3,900 | $74K | |
| 2020 | 4,212 | $95K | |
| 2021 | 4,417 | $67K | |
| 2022 | 3,733 | $64K | |
| 2023 | 2,465 | $32K | |
| 2024incomplete | 1,587 | $24K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 62% | 8,696 | 7,199 | $259K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 11% | 811 | 741 | $47K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.1% | 669 | 612 | $30K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4.1% | 209 | 175 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.9% | 542 | 451 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 2,565 | 2,010 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.8% | 769 | 685 | $12K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.0% | 183 | 170 | $8K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.0% | 87 | 78 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,670 | 2,450 | $4K |
| 81003 | <1% | 2,285 | 2,010 | $3K | |
| 82962 | <1% | 1,420 | 1,182 | $3K |
22 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 152 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 32 | $943.97 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 518 | $921.11 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 13 | $672.58 |
| 86328 | <1% | 21 | $669.38 | |
| 86769 | <1% | 15 | $505.50 | |
| 92551 | <1% | 74 | $500.17 | |
| 90756 | <1% | 30 | $478.59 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 13 | $447.04 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 470 | $339.51 |
| 90688 | <1% | 31 | $338.96 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 551 | $331.24 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 95 | $164.13 |
| 99406 | <1% | 52 | $143.21 | |
| 86308 | <1% | 25 | $86.52 | |
| 99173 | <1% | 75 | $43.33 | |
| 85018 | <1% | 67 | $28.37 | |
| 97803 | <1% | 201 | $28.08 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 110 | $6.12 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 179 | $4.79 |
| 97802 | 0% | 291 | $0.00 | |
| 36416 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.